Related Experiment Video
Updated: Jul 15, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Left ventricular hypertrophy, subclinical atherosclerosis, and inflammation
Sameer K Mehta1, J Eduardo Rame, Amit Khera
1Donald W. Reynolds Cardiovascular Clinical Research Center and Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9047, USA.
Left ventricular hypertrophy (LVH) is linked to coronary artery calcium (CAC) and atherosclerosis. Concentric LVH independently predicts subclinical atherosclerosis, explaining increased heart attack risk.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Biomarkers
Background:
- Left ventricular hypertrophy (LVH) is a known risk factor for atherosclerotic heart disease.
- Mechanisms linking LVH to atherosclerosis require further elucidation.
Purpose of the Study:
- To determine if LVH is independently associated with coronary artery calcium (CAC) and C-reactive protein (CRP) in the general population.
- To investigate the relationship between LVH markers and subclinical atherosclerosis.
Main Methods:
- Utilized data from the Dallas Heart Study, a population-based sample of 2633 individuals.
- Cardiac MRI measured LV structure; electron beam CT measured CAC; plasma CRP levels were measured.
- Univariate and multivariable analyses assessed associations between LVH markers, CAC, and CRP.
Main Results:
- Increasing LV mass, LV wall thickness, and concentricity were associated with CAC (P<0.001).
- LV wall thickness and concentricity remained independently associated with CAC after adjusting for traditional risk factors.
- Associations were stronger in Black individuals and showed a trend with elevated CRP levels.
Conclusions:
- Concentric LVH is an independent risk factor for subclinical atherosclerosis.
- LVH is associated with an inflammatory state, potentially explaining increased myocardial infarction risk.
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis I: Introduction

